Sept 25 (Reuters)-
Pharmarise Holdings Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Aug 31, 2025 Aug 31, 2024 May 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 16.75 15.23 66.80
(+10.0 pct) (+13.1 pct) (+5.2 pct)
Operating 152 mln 52 mln 1.12
(+188.5 pct) (-84.1 pct) (+282.2 pct)
Recurring 115 mln 23 mln 941 mln
(+399.1 pct) (-93.0 pct) (+587.3 pct)
Net loss 18 mln loss 131 mln 266 mln
EPS loss 1.62 yen loss 11.68 yen 23.45 yen
Ann Div 14.00 yen 14.00 yen
-Q2 div NIL NIL
-Q4 div 14.00 yen 14.00 yen
NOTE - Pharmarise Holdings Corp.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T